Detalles de la búsqueda
1.
Correction: Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells.
Br J Cancer;
122(12): 1872, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32303715
2.
Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells.
Br J Cancer;
121(7): 600-610, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31481733
3.
Machine learning for prediction of cutaneous adverse events in patients receiving anti-PD-1 immunotherapy.
J Am Acad Dermatol;
84(1): 183-185, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32334053
4.
Natural history of SCLC patients treated in third-line and beyond: A retrospective real world study.
Lung Cancer;
193: 107819, 2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38865854
5.
Symptoms and Experiences with Small Cell Lung Cancer: A Mixed Methods Study of Patients and Caregivers.
Pulm Ther;
9(3): 435-450, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37310567
6.
CXCR4 expression in lung carcinogenesis: Evaluating gender-specific differences in survival outcomes based on CXCR4 expression in early stage non-small cell lung cancer patients.
PLoS One;
16(1): e0241240, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33507926
7.
Retrospective Real-World Outcomes for Patients With ALK-Rearranged Lung Cancer Receiving ALK Receptor Tyrosine Kinase Inhibitors.
JTO Clin Res Rep;
2(4): 100157, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34590010
8.
A Real-World Evaluation of Atezolizumab Plus Platinum-Etoposide Chemotherapy in Patients With Extensive-Stage SCLC in Canada.
JTO Clin Res Rep;
2(12): 100249, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34877555
9.
Real-World Treatment Patterns, Clinical Outcomes, and Health Care Resource Utilization in Extensive-Stage Small Cell Lung Cancer in Canada.
Curr Oncol;
28(4): 3091-3103, 2021 08 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34436036
10.
Effectiveness and Safety of First-Line Pembrolizumab in Older Adults with PD-L1 Positive Non-Small Cell Lung Cancer: A Retrospective Cohort Study of the Alberta Immunotherapy Database.
Curr Oncol;
28(5): 4213-4222, 2021 10 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34677275
11.
Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Adults.
Curr Oncol;
28(1): 523-548, 2021 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33467570
12.
The prevalence and prognostic significance of estrogen receptor beta expression in non-small cell lung cancer.
Transl Lung Cancer Res;
9(3): 496-506, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32676313
13.
The Population-based Impact of Adjuvant Chemotherapy on Outcomes in T2N0M0 Non-Small Cell Lung Cancer.
Am J Clin Oncol;
43(7): 496-503, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32349021
14.
Population-based Treatment Patterns and Outcomes for Stage III Non-Small Cell Lung Cancer Patients: A Real-world Evidence Study.
Am J Clin Oncol;
43(9): 615-620, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32889830
15.
Physical activity and diet behaviour in colorectal cancer patients receiving chemotherapy: associations with quality of life.
BMC Gastroenterol;
9: 60, 2009 Jul 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-19635164
16.
The Lung Immune Prognostic Index Discriminates Survival Outcomes in Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors.
Cancers (Basel);
11(11)2019 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31684111
17.
Factors associated with early mortality in non-small cell lung cancer patients following systemic anti-cancer therapy: A 10 year population-based study.
Lung Cancer;
134: 141-146, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31319972
18.
Associations of objectively assessed physical activity and sedentary time with health-related quality of life among lung cancer survivors: A quantile regression approach.
Lung Cancer;
119: 78-84, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29656757
19.
Impact of number versus location of metastases on survival in stage IV M1b non-small cell lung cancer.
Med Oncol;
35(9): 117, 2018 Aug 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30073425
20.
ATM-Deficient Colorectal Cancer Cells Are Sensitive to the PARP Inhibitor Olaparib.
Transl Oncol;
10(2): 190-196, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28182994